Recursion Pharmaceuticals Inc.
Nasdaq RXRX · Salt Lake City, UT
Works in Cardiovascular · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Neurology · Oncology
Recursion Pharmaceuticals Inc. is a clinical trial sponsor based in Salt Lake City, UT, listed as Nasdaq RXRX. It has 3 active clinical trials with 327 planned participants, across 9 therapeutic areas. Since 2021 it has completed 1 trial and stopped 3 early.
Trial track record · since 2021
Financials · Nasdaq RXRX
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals Inc is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 327 planned participants, in Cardiovascular, ENT, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 1 trial and stopped 3 early.
Recursion Pharmaceuticals Inc is based in Salt Lake City, UT and is listed as Nasdaq RXRX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Recursion Pharmaceuticals Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-29.
Approve Suite is not affiliated with Recursion Pharmaceuticals Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.